J9281 HCPCS code: Mitomycin pyelocalyceal instillation, 1 mg
J9281 is the HCPCS Level II code for mitomycin pyelocalyceal instillation, 1 mg. In 2024 Medicare paid an average of $226.83 per service for J9281 across 72,795 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 80 per day on outpatient hospital claims. Medicare volume rose 45% from 2022 to 2024 (50,128 to 72,795 services). In 2024, about 186 clinicians billed Medicare for J9281 for 211 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 2021-01-01 |
| Last action effective | 2021-01-01 |
Who bills J9281 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 186 |
| Medicare beneficiaries | 211 |
| States with claims | 4 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9281, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 50,128 | 160 | $269.19 | $214.76 |
| 2023 | 73,047 | 201 | $286.33 | $228.13 |
| 2024 | 72,795 | 211 | $284.70 | $226.83 |
States with the most J9281 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 6,799 | $237.80 |
| Massachusetts | 5,360 | $237.82 |
| Georgia | 4,521 | $238.88 |
| South Carolina | 3,160 | $86.10 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 80 | CMS Policy |
| practitioner claims | 80 | CMS Policy |
What changed for J9281
- 2021-01-01: J9281 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9281?
J9281 is the HCPCS Level II code for mitomycin pyelocalyceal instillation, 1 mg. Short descriptor: "Mitomycin instillation".
How much does Medicare pay for J9281?
In 2024, the average Medicare payment was $226.83 per service (average allowed $284.70).
Does Medicare cover J9281?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9281 can be billed per day?
80 on outpatient hospital claims; 80 on practitioner claims (NCCI medically unlikely edits).
Related J92 codes
- J9200 — Injection, floxuridine, 500 mg
- J9201 — Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
- J9202 — Goserelin acetate implant, per 3.6 mg
- J9203 — Injection, gemtuzumab ozogamicin, 0.1 mg
- J9204 — Injection, mogamulizumab-kpkc, 1 mg
- J9205 — Injection, irinotecan liposome, 1 mg
- J9206 — Injection, irinotecan, 20 mg
- J9207 — Injection, ixabepilone, 1 mg
- J9208 — Injection, ifosfamide, 1 gram
- J9209 — Injection, mesna, 200 mg
- J9210 — Injection, emapalumab-lzsg, 1 mg
- J9211 — Injection, idarubicin hydrochloride, 5 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9281
- Watch J9281 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9281
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.